Loading...
Loading...
India's empagliflozin imports from GERMANY total $63.7B across 237 shipments from 15 foreign suppliers. BOEHRINGER INGELHEIM INTERNATIONAL leads with $63.7B in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include BOEHRINGER INGELHEIM INDIA PRIVATE LIMITED. This corridor reflects India's pharmaceutical import demand for empagliflozin — a diversified sourcing base with multiple active suppliers from GERMANY.

BOEHRINGER INGELHEIM INTERNATIONAL is the leading Empagliflozin supplier from GERMANY to India, with import value of $63.7B across 154 shipments. The top 5 suppliers — BOEHRINGER INGELHEIM INTERNATIONAL, BOEHRINGER INGELHEIM INTERNATIONAL GMBH, ALMAC CLINICAL SERVICES., BOEHRINGER INGELHEIM INDIA PRIVATE LIMITED, ALMAC CLINICAL SERVICES — collectively account for 100.0% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | BOEHRINGER INGELHEIM INTERNATIONAL | $63.7B | 154 | 100.0% |
| 2 | BOEHRINGER INGELHEIM INTERNATIONAL GMBH | $384.3K | 1 | 0.0% |
| 3 | ALMAC CLINICAL SERVICES. | $133.1K | 1 | 0.0% |
| 4 | BOEHRINGER INGELHEIM INDIA PRIVATE LIMITED | $88.5K | 1 | 0.0% |
| 5 | ALMAC CLINICAL SERVICES | $51.5K | 4 | 0.0% |
| 6 | PRIVAPOSERVICES GMBH | $13.5K | 25 | 0.0% |
| 7 | ILAPO-INTERNATIONALE LUDWIGS- | $11.5K | 2 | 0.0% |
| 8 | NewLife Biopharma Limited | $8.1K | 2 | 0.0% |
| 9 | DERMA & DERMO COMERCIO DE PRODUTOS DERMATOLOGICOS | $7.7K | 1 | 0.0% |
| 10 | NEWLIFE BIOPHARMA LIMITED | $7.5K | 5 | 0.0% |
| 11 | BILCARE GCS IRELAND LIMITED | $6.3K | 4 | 0.0% |
| 12 | RX SOLUTION LIMITED | $6.3K | 6 | 0.0% |
| 13 | TORRENT DO BRASIL LTDA | $3.0K | 3 | 0.0% |
| 14 | CUBIC PHARMACEUTICALS LTD | $2.9K | 3 | 0.0% |
| 15 | NEWLIFE BIOPHARMA LIMITED. | $2.9K | 2 | 0.0% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | BOEHRINGER INGELHEIM INDIA PRIVATE LIMITED | $63.7B | 155 | 100.0% |
| 2 | GEORGE INSTITUTE SERVICES INDIA PRIVATE LIMITED | $133.1K | 1 | 0.0% |
| 3 | SRIKARAM PRESCIENCE PRIVATE LIMITED | $88.5K | 1 | 0.0% |
| 4 | LABCORP DRUG DEVELOPMENT INDIA PRIVATE LIMITED | $51.5K | 4 | 0.0% |
| 5 | WATSON PHARMA PRIVATE LIMITED | $11.5K | 2 | 0.0% |
| 6 | CLIANTHA RESEARCH LIMITED | $8.6K | 2 | 0.0% |
| 7 | ALEMBIC PHARMACEUTICALS LIMITED | $8.1K | 2 | 0.0% |
| 8 | MICRO LABS LTD | $6.3K | 4 | 0.0% |
| 9 | USV PRIVATE LIMITED | $5.8K | 10 | 0.0% |
| 10 | IPCA LABORATORIES LIMITED | $5.5K | 4 | 0.0% |
| 11 | PINNACLE LIFE SCIENCE PRIVATE LIMITED | $5.3K | 6 | 0.0% |
| 12 | DR.REDDY'S LABORATORIES LTD | $4.2K | 9 | 0.0% |
| 13 | COPMED PHARMACEUTICALS PRIVATE LIMITED | $3.2K | 4 | 0.0% |
| 14 | TORRENT PHARMACEUTICALS LTD | $3.0K | 3 | 0.0% |
| 15 | VERGO PHARMA RESEARCH LABORATORIES PRIVATE LIMITED | $2.8K | 1 | 0.0% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Empagliflozin suppliers from GERMANY to India include BOEHRINGER INGELHEIM INTERNATIONAL, BOEHRINGER INGELHEIM INTERNATIONAL GMBH, ALMAC CLINICAL SERVICES.. The leading supplier is BOEHRINGER INGELHEIM INTERNATIONAL with import value of $63.7B USD across 154 shipments. India imported Empagliflozin worth $63.7B USD from GERMANY in total across 237 shipments.
India imported Empagliflozin worth $63.7B USD from GERMANY across 237 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Empagliflozin sourced from GERMANY include BOEHRINGER INGELHEIM INDIA PRIVATE LIMITED, GEORGE INSTITUTE SERVICES INDIA PRIVATE LIMITED, SRIKARAM PRESCIENCE PRIVATE LIMITED. The largest buyer is BOEHRINGER INGELHEIM INDIA PRIVATE LIMITED with $63.7B in imports across 155 shipments.
The total value of Empagliflozin imports from GERMANY to India is $63.7B USD, across 237 shipments and 15 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
237 Verified Shipments
15 suppliers, 15 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists